- Human Biospecimens
- For Researchers
- For Biospecimen Contributors
- For Patients
September 12, 2019
Liquid biopsies are among the most exciting areas of medical diagnostics. Although the technology is in its early stages, the hope is that liquid biopsies – through a simple draw of blood or other human biofluids – will detect cancer earlier and without the invasiveness of surgical or needle biopsies. The procedure could one day be simple and cost-effective enough to conduct in the doctor’s office or in the comfort of one’s own home, even before symptoms arise.
Our second Specimen Insight podcast episode, “Fast-Tracking Liquid Biopsy Development Through Better Biospecimen Collection,” features a conversation with Eric Langlois, iSpecimen’s senior vice president of sales and business development. For decades, Eric has consulted with research organizations to help them acquire the specimens they need to advance their work. Recently, he has been working closely with numerous clients who are leading liquid biopsy studies to satisfy specific patient, specimen, collection, processing and delivery requirements. The resulting collections leverage iSpecimen’s extensive pre-established patient network with its pre-established protocols, which together save clients a lot of time that they would otherwise spend building collection infrastructures from the ground up.
Listen to the podcast episode to learn:
For more on liquid biopsies, check out these resources:
Don’t forget to listen to the first episode of our Specimen Insight podcast series, as well!
Learn about the iSpecimen Marketplace where you can browse millions of richly annotated, de-identified human tissue and biofluid biospecimens, in addition to hematopoietic and immune cell products. You can join for free and creating a login is easy. Request a quote or custom collection today.